AstraZeneca develops new vaccine reducing COVID-19 risk symptoms by 83%
AstraZeneca developed new vaccine (AZD7442) that proved to be effective in reducing COVID-19 risk symptoms ...
vaccine
AU to get 220 m vaccine doses by 2022 under deal with UNICEF
UNICEF has signed an agreement with Janssen Pharmaceutica NV to supply up to 220 million doses of ...
Facebook seeks extending vaccines to underserved communities in US
Facebook have launched campaign to drum up efforts to help Black, Latinx, Native American, Asian ...
G7 countries expected to donate 1 billion doses by the end of 2021
Several forecasts suggest that G7 countries will have enough vaccine supplies to donate 1 billion ...
European Commission authorizes AstaZeneca’s COVID-19 vaccine
The European Commission has granted a conditional marketing authorization (CMA) for the COVID‑19 vaccine developed ...
TMG to secure COVID-19 vaccine for 2 m vulnerable people
Talaat Moustafa Group (TMG) Holding will bear the cost for securing COVID-19 vaccine for 2 million ...
UK authorizes emergency use of Oxford University vaccine
The UK Government has today accepted the recommendation from the Medicines and Healthcare products Regulatory ...
Oxford university’s vaccine in phase III trials offers high level of protection
The University of Oxford, in collaboration with AstraZeneca plc, announced interim trial data from its ...
Germany eyes voluntary COVID-19 vaccine by mid-2021
Germany aims to reach herd immunity through a voluntary coronavirus vaccine expected to be widely ...
The Oxford University AstraZeneca Covid-19 vaccine trial has been paused – should we be worried?
The halt in development of the University of Oxford’s Covid-19 vaccine due to an adverse reaction in a ...
Johnson & Johnson to start late-stage coronavirus vaccine trial in September with up to 60,000 people
Johnson & Johnson plans to begin what would be the largest, late-stage trial testing a potential ...
World’s first phase III clinical trial of COVID-19 inactivated vaccine begins in UAE
The first World Health Organization,WHO, enlisted global clinical Phase III trial of Sinopharm CNBG’s inactivated ...
The race to find a COVID-19 vaccine
It’s not an understatement to say that the entire nation’s hopes are focused on what’s ...
Global fundraising for COVID-19 vaccine, drugs exceeds $10 bn, EU says
A global campaign to fund the development of vaccines and therapies against COVID-19 has so ...
Nestlé donates over $1m for CEPI’s CVOID-19 vaccine search
Nestlé announced that it will donate about $ 1.03 million to help the Coalition for ...
Oxford Univ. gets £65.5 m for developing COVID-19 vaccine
Oxford University will get £65.5 million finance from the UK government as efforts to produce ...
UK largest contributor to CEPI with £544 m allocated for COVID-19 vaccine
The UK became the largest contributor to the Coalition for Epidemic Preparedness Innovations (CEPI) – ...